Immediately discontinue peptide administration in the event of a severe adverse reaction in research
Peptides are an incredibly powerful, natural treatment option for a variety of health concerns, from sexual health to gut health to muscle health
BPC-157 has been discussed by the FDA in the context of bulk drug substances that may present significant safety risks, and TB-500 is generally promoted in research-peptide settings rather than as an FDA-approved therapeutic product
However, patients should understand the regulatory landscape, potential side effects, and contraindications before beginning treatment
Compared to cognitively normal participants, individuals with mild cognitive impairment exhibit a relative increase in pro-inflammatory bacterial taxa and a reduction in bacteria associated with metabolic homeostasis at baseline, while fecal concentrations of acetate, propionate, and butyrate did not significantly differ [66]